Volume 79, no. 3, p. 1367-1378, 2005. The publisher hereby retracts the above article due to evidence of data manipulation, a clear violation of ASM's ethical standards.
. 2011 Feb;85(3):1416. doi: 10.1128/JVI.02070-10
Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines
Takehiro Matsuda
1, Alex Almasan
1, Mariko Tomita
1, Jun-nosuke Uchihara
1, Masato Masuda
1, Kazuiku Ohshiro
1, Nobuyuki Takasu
1, Hideo Yagita
1, Takao Ohta
1, Naoki Mori
1
Takehiro Matsuda
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Takehiro Matsuda
Alex Almasan
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Alex Almasan
Mariko Tomita
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Mariko Tomita
Jun-nosuke Uchihara
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Jun-nosuke Uchihara
Masato Masuda
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Masato Masuda
Kazuiku Ohshiro
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Kazuiku Ohshiro
Nobuyuki Takasu
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Nobuyuki Takasu
Hideo Yagita
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Hideo Yagita
Takao Ohta
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Takao Ohta
Naoki Mori
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Find articles by Naoki Mori
1Division of Molecular Virology and Oncology, Graduate School of Medicine, and Division of Child Health and Welfare and Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara, and Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa, and Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, and Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
PMCID: PMC3020492 PMID: 21228250
This retracts the article "Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines" in volume 79 on page 1367.